Israel Biotech Fund II, L.P. insider trades: Ayala Pharmaceuticals (ADXS) SEC Form 4 filings
Companies
Where Israel Biotech Fund II, L.P. reports to the SEC
About Israel Biotech Fund II, L.P.'s insider trades
Israel Biotech Fund II, L.P. is a director at Ayala Pharmaceuticals (ADXS). It has not reported an open-market purchase or sale.
Its filings also include option exercises (2 filings), other transactions (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADXS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.